Evidence map›Paper›PMID 23287719›Full record

ArticleScience (New York, N.Y.)2013

A strategy for modulation of enzymes in the ubiquitin system.

Andreas Ernst, George Avvakumov, Jiefei Tong, Yihui Fan, Yanling Zhao, Philipp Alberts, Avinash Persaud, John R Walker, Ana-Mirela Neculai, Dante Neculai and 22 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 295 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. E2 variants for probing E3 ubiquitin ligase activities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Inhibiting Infectious Bronchitis Virus PLpro Using Ubiquitin Variants.International journal of molecular sciences · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 5 institutions in 2 countries.

Andreas ErnstTerrence Donnelly Center for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario, Canada.
George Avvakumov
Jiefei Tong
Yihui Fan
Yanling Zhao
Philipp Alberts
Avinash Persaud
John R Walker
Ana-Mirela Neculai
Dante Neculai
Andrew Vorobyov
Pankaj Garg
Linda Beatty
Pak-Kei Chan
Yu-Chi Juang
Marie-Claude Landry
Christina Yeh
Elton Zeqiraj
Konstantina Karamboulas
Abdellah Allali-Hassani
Masoud Vedadi
Mike Tyers
Jason Moffat
Frank Sicheri
Laurence Pelletier
Daniel Durocher
Brian Raught
Daniela Rotin
Jianhua Yang
Michael F Moran
Sirano Dhe-Paganon
Sachdev S Sidhu
University of Toronto · CAMount Sinai Hospital · CALunenfeld-Tanenbaum Research Institute · CAChildren's Cancer Center · USBaylor College of Medicine · US

Funding

DUSP26: A Novel Therapeutic Target in NeuroblastomaR01NS072420 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI YANG, JIANHUA · 2011 to 2014
$1.4M
CIHR 1R01NS072420-01CIHR MOP-102536CIHR MOP-111149CIHR MOP-13494CIHR MOP-57795NINDS NIH HHS R01 NS072420Wellcome Trust 092076Wellcome Trust 092381
6 · The paper itself

Abstract

The ubiquitin system regulates virtually all aspects of cellular function. We report a method to target the myriad enzymes that govern ubiquitination of protein substrates. We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallography. We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity. Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains. Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymatic steps in the ubiquitin system.

Indexed as

Combinatorial Chemistry TechniquesAmino Acid SequenceConserved SequenceDrug DesignEndopeptidasesHEK293 CellsHumansMolecular Sequence DataProtease InhibitorsProtein ConformationProtein Structure, SecondarySmall Molecule LibrariesUbiquitinUbiquitinationUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesEndopeptidasesProtease InhibitorsSmall Molecule LibrariesUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-Protein LigasesUbiquitin ThiolesteraseUSP21 protein, human

Identifiers

PMID23287719
PMCPMC3815447
OpenAlexW1974389826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.